Article
How to optimize HCV therapy in genotype 4 patients.
Liver international : official journal of the International Association for the Study of the Liver - 1 Feb 2013
Esmat Gamal, El Kassas Mohamed, Hassany Mohamed, Gamil Mohamed Esmat, El Raziky Maisa
Abstract excerpt
HCV is a worldwide disease with an estimated prevalence by WHO of 3%. Hepatitis C virus 4 is prevalent in Africa and the Middle East, especially Egypt. The treatment of HCV4 is affected by many factors, related to the virus itself (genotype, pretreatment viral load and prevalent quasispecies), to the host (genetic factors, age, ethnicity and liver histology), to the presence of comorbidities (obesity, insulin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.